Prevalence of signs and symptoms suggestive dysbiosis intestinal in an academic higher education institution

• Autor(a) principal: Alves, Bárbara Karoline Rêgo Beserra
• Data de Publicação: 2020
• Outros Autores: Santos, Leandra Caline dos, Sousa, Paulo Ví­ctor de Lima, Santos, Gleyson Moura dos, Barros, Nara Vanessa dos Anjos
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Revista brasileira de obesidade, nutrição e emagrecimento
• Texto Completo: https://www.rbone.com.br/index.php/rbone/article/view/1324
• topic: Gastrointestinal Microbiome; Dysbiosis; Digestive signs and symptoms; Microbioma gastrointestinal; Disbiose; Sinais e sintomas digestivos

Intestinal dysbiosis is a health-damaging condition caused by qualitative and quantitative changes in the intestinal microbiota. The present study aimed to determine the prevalence of signs and symptoms suggestive of intestinal dysbiosis in the Nutrition course of a Public Institution of Higher Education. It is a quantitative, descriptive, and cross-sectional research. Data collection was performed from september to november 2018, through the application of two questionnaires: an elaborated questionnaire addressing socioeconomic information and the Metabolic Tracing Questionnaire, from the Brazilian Institute of Functional Nutrition. The study sample comprised 186 students, of which 151 (81.19%) were female and 35 (18.81%) were male, ranging in age from 18 to 60 years. The results suggested that the prevalence of signs and symptoms suggestive of intestinal dysbiosis among nutrition students (97.31%) is high. The indicative of hypersensitivity that may be suggestive of dysbiosis was observed in 43.01% (n = 80) of the evaluated subjects. The most prevalent symptom reported by the participants was distended abdominal / abdominal swelling, with a percentage of 57.53%, of an audience of 107 people. Thus, it is important to pay attention to the in-depth knowledge of the composition and activity of the intestinal microbiota, since this process should lead to new therapeutic interventions based on the possible modulation of this microbiome, resulting in an improvement in patients' quality of life.